According to a study conducted by researchers at the South Australian Health and Medical Research Institute (SAHMRI), pregnant women who received magnesium sulfate intravenously did not see their children suffer from any particular problems.
The main author of the study is Emily Shepherd, who says that this is an important result because it reassures all parents and especially all pregnant women who need to take magnesium sulfate.
The same researcher talks about what has been speculation that this beneficial treatment could unintentionally harm the unborn child, but the issue has never actually been clearly addressed.
The study is, in fact, a systematic review of nearly 200 other studies, 40 of which are randomized, which allowed the researcher to achieve the result that it is not possible to find any particular differences for newborns whose mothers were treated with magnesium sulfate during pregnancy compared to mothers who were not treated with this substance or who were treated with placebo.
Magnesium sulphate is taken especially for pregnant women with pre-eclampsia or eclampsia and over the past 10 years, it has been introduced as a treatment even for pregnant women who are likely to have a very premature child in order to reduce the risk of developing cerebral palsy in their child.
“Our results support the continued use of magnesium sulfate as a safe treatment for these women, as well as for pregnant women with pre-eclampsia or eclampsia,” says the researcher. The study was published in PLOS Medicine.